[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339171-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339171-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","csn6-spop-hmgcs1-axis-promotes-hepatocellular-carcinoma-progression-via-yap1-activation-research-article","CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation - research article","","Cholesterol metabolism is crucial for membrane integrity and disease development, yet therapies targeting cholesterol synthesis in cancer are often limited. This study shows CSN6 is elevated in hepatocellular carcinoma (HCC) and acts as a positive regulator of HMGCS1 within the mevalonate (MVA) pathway. CSN6 antagonizes SPOP ubiquitin ligase, stabilizing HMGCS1, which activates YAP1 to drive tumor growth. In orthotopic models, targeting CSN6/HMGCS1 suppresses tumors in both standard and high-fat diets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/csn6-spop-hmgcs1-axis-promotes-hepatocellular-carcinoma-progression-via-yap1-activation-research-article/339171/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/csn6-spop-hmgcs1-axis-promotes-hepatocellular-carcinoma-progression-via-yap1-activation-research-article/339171.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does CSN6 play in hepatocellular carcinoma progression?","Question",{"text":63,"@type":64},"CSN6 is elevated in HCC and promotes tumorigenesis by positively regulating HMGCS1 in the mevalonate (MVA) pathway and driving downstream YAP1 activation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does CSN6 regulate HMGCS1 mechanistically?",{"text":68,"@type":64},"CSN6 antagonizes the SPOP ubiquitin ligase, stabilizing HMGCS1 so it can activate YAP1 and promote tumor growth.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic effect is observed when targeting CSN6 and HMGCS1?",{"text":72,"@type":64},"Targeting CSN6 and HMGCS1 hinders tumor growth in orthotopic liver cancer models under both normal diet and high-fat diet conditions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339171,1790198125,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \nCSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation  \nKai Li, Jiayu Zhang, Haiwen Lyu, Jinneng Yang, Wenxia Wei, Yuzhi Wang, Haidan Luo, Yijing Zhang, XinJiang, Hairong Yi, Mengan Wang, Caiyun Zhang, Kang Wu, Lishi Xiao, Weijie Wen, Hui Xu, Guolin Li, Yunle Wan, Fang Yang, Runxiang Yang, Xinhui Fu,  \nBaifu Qin, Zhongguo Zhou,* Haipeng Zhang,* and Mong-Hong Lee*  \nCholesterol metabolism has important roles in maintaining membrane integrity and countering the development of diseases such as obesity and cancers. Cancer cells sustain cholesterol biogenesis for their proliferation and microenvironment reprograming even when sterols are abundant. However, eﬃcacy of targeting cholesterol metabolism for cancer treatment is always compromised. Here it is shown that CSN6 is elevated in HCC and is a positive regulator of hydroxymethylglutaryl-CoA synthase 1 (HMGCS1) of mevalonate (MVA) pathway to promote tumorigenesis. Mechanistically, CSN6 antagonizes speckle-type POZ protein (SPOP) ubiquitin ligase to stabilize HMGCS1, which in turn activates YAP1 to promote tumor growth. In orthotopic liver cancer models, targeting CSN6 and HMGCS1 hinders tumor growth in both normal and high fat diet. Signiﬁcantly, HMGCS1 depletion improves YAP inhibitor eﬃcacy in patient derived xenograft models. The results identify a CSN6-HMGCS1-YAP1 axis mediating tumor outgrowth in HCC and propose a therapeutic strategy of targeting non-alcoholic fatty liver diseases-associated HCC.  \n1. Introduction  \nLiver cancer, 90% of primary liver cancers are HCC, is increasing globally and is the second leading cause of cancerrelated death. [1] The liver serves as a central metabolic coordinator with a wide array of essential functions, including the regulation of glucose, lipid metabolism and bile acid synthesis. [2] The major risk factors of HCC include hepatitis viral infection, aﬂatoxin contamination and liver metabolic diseases. Among these risk factors, nonalcoholic fatty liver diseases (NAFLD) is predicted to become the leading cause of HCCin the future as a secondary consequence of the obesity pandemic. [3] However, treatment of NAFLD-associated cancer remains to be further explored.  \nCholesterol has multiple physiological roles, including modulation of membrane  \nK. Li, J. Zhang, H. Lyu, J. Yang, W. Wei, Y. Wang, H. Luo, Y. Zhang,  \nX. Jiang, H. Yi, M. Wang, C. Zhang, L. Xiao, W. Wen, H. Xu, G. Li, Y. Wan, X. Fu, B. Qin, M.-H. Lee  \nGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease  \nThe Sixth Aﬃliated Hospital Sun Yat-sen University Guangzhou 510655, China  \nE-mail: [limh33@mail.sysu.edu.cn](limh33@mail.sysu.edu.cn)  \nK. Li, J. Zhang, H. Lyu, J. Yang, W. Wei, Y. Wang, H. Luo, Y. Zhang, X. Jiang,  \nH. Yi, M. Wang, C. Zhang, L. Xiao, W. Wen, H. Xu, X. Fu, B. Qin, M.-H. Lee Guangdong Research Institute of Gastroenterology  \nThe Sixth Aﬃliated Hospital SunYat-sen University Guangzhou 510655, China  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202306827](https://doi.org/10.1002/advs.202306827)[ ](https://doi.org/10.1002/advs.202306827)© 2024 The Authors. Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202306827  \nK. Li, J. Zhang, H. Lyu, J. Yang, W. Wei, Y. Wang, H. Luo, Y. Zhang,  \nX. Jiang, H. Yi, M. Wang, C. Zhang, L. Xiao, W. Wen, H. Xu, G. Li, Y. Wan, X. Fu, B. Qin, M.-H. Lee  \nKey Laboratory of Human Microbiome and Chronic Diseases (Sun Yat-sen University)  \nMinistry of Education Guangzhou 510655, China  \nK. Li, J. Zhang, H. Lyu, J. Yang, W. Wei, Y. Wang, H. Luo, Y. Zhang, X. Jiang, H. Yi, M. Wang, C. Zhang, L. Xiao, W. Wen, H. Xu, X. Fu, B.","cbCaijIyLYZWQQUO","https://ap.wps.com/l/cbCaijIyLYZWQQUO","pdf",9623219,17,"English","# Introduction\n## Background: HCC, metabolic regulation, and NAFLD\n## Cholesterol and the mevalonate (MVA) pathway in cancer\n## Rationale: unresolved mechanisms and therapeutic challenges\n# CSN6 and the CSN6-SPOP-HMGCS1-YAP1 axis","[{\"question\":\"What role does CSN6 play in hepatocellular carcinoma progression?\",\"answer\":\"CSN6 is elevated in HCC and promotes tumorigenesis by positively regulating HMGCS1 in the mevalonate (MVA) pathway and driving downstream YAP1 activation.\"},{\"question\":\"How does CSN6 regulate HMGCS1 mechanistically?\",\"answer\":\"CSN6 antagonizes the SPOP ubiquitin ligase, stabilizing HMGCS1 so it can activate YAP1 and promote tumor growth.\"},{\"question\":\"What therapeutic effect is observed when targeting CSN6 and HMGCS1?\",\"answer\":\"Targeting CSN6 and HMGCS1 hinders tumor growth in orthotopic liver cancer models under both normal diet and high-fat diet conditions.\"}]","CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation - research article | PDF",1790028357,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d80e830f13293bd0b5742f01d1a412d.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5718c2e75fba0bdfdde6974f7695317e.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dbb1779d8571fd2faac8ccfb5de5a93.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb719d343bfbfad8d5f8679777991acd.webp",980,1287]